Total Payments
$271.64
2019 Payments
$34.16
Companies
12
Transactions
22
Medicare Patients
8,257
Medicare Billing
$764,299
Payment Breakdown by Category
Food & Beverage$271.64 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $271.64 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $72.04 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $47.48 | 4 | $0 (2018) |
| Novo Nordisk Inc | $34.74 | 3 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $17.38 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $14.77 | 1 | $0 (2017) |
| Strongbridge US INC. | $13.24 | 1 | $0 (2018) |
| Lilly USA, LLC | $13.08 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.59 | 1 | $0 (2018) |
| PFIZER INC. | $12.41 | 1 | $0 (2018) |
| Purdue Pharma L.P. | $12.30 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $34.16 | 3 | Novo Nordisk Inc ($22.72) |
| 2018 | $151.49 | 12 | Astellas Pharma US Inc ($38.59) |
| 2017 | $85.99 | 7 | Janssen Pharmaceuticals, Inc ($24.11) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Diabetes | ||||||
| 11/18/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Diabetes | ||||||
| 06/04/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: UROLOGY | ||||||
| 11/26/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: UROLOGY | ||||||
| 11/15/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: UROLOGY | ||||||
| 11/02/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/29/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: DIABETES | ||||||
| 06/11/2018 | Purdue Pharma L.P. | — | Food and Beverage | Cash or cash equivalent | $12.30 | General |
| 05/18/2018 | Strongbridge US INC. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Neurology | ||||||
| 04/30/2018 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: UROLOGY | ||||||
| 01/22/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: VACCINES | ||||||
| 01/10/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $17.38 | General |
| Category: AED | ||||||
| 12/11/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 09/27/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Diabetes | ||||||
| 07/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), XARELTO | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Urology | ||||||
| 01/24/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Urology | ||||||
| 01/06/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,116 | 5,419 | $453,034 | $203,287 |
| 2022 | 21 | 1,897 | 4,298 | $402,258 | $196,837 |
| 2021 | 20 | 2,199 | 7,126 | $431,440 | $198,384 |
| 2020 | 25 | 2,045 | 9,338 | $403,467 | $165,790 |
Total Patients
8,257
Total Services
26,181
Medicare Billing
$764,299
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 342 | 462 | $119,390 | $55,626 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 310 | 310 | $72,339 | $38,059 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 341 | $65,356 | $30,045 | 46.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 1,020 | $49,082 | $17,968 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 160 | $20,829 | $9,507 | 45.6% |
| 77067 | Screening mammography | Office | 2023 | 93 | 93 | $16,275 | $7,928 | 48.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 37 | 49 | $14,432 | $7,514 | 52.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 361 | 795 | $12,720 | $6,641 | 52.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 73 | 74 | $8,510 | $5,599 | 65.8% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 18 | 18 | $9,040 | $4,343 | 48.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $5,378 | $3,305 | 61.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $5,171 | $2,356 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 79 | $2,844 | $2,259 | 79.4% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 93 | 93 | $4,008 | $2,065 | 51.5% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 11 | 11 | $6,254 | $1,880 | 30.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 24 | $3,937 | $1,705 | 43.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 31 | 40 | $3,740 | $1,525 | 40.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 32 | $2,478 | $1,361 | 54.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 28 | 48 | $1,824 | $733.88 | 40.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $632.70 | $543.40 | 85.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 24 | 24 | $4,662 | $449.17 | 9.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 24 | 24 | $5,310 | $375.36 | 7.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 35 | 79 | $2,697 | $331.80 | 12.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 54 | 56 | $4,554 | $312.77 | 6.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 32 | $1,439 | $299.04 | 20.8% |
About Dr. Sandra Killingsworth, MD
Dr. Sandra Killingsworth, MD is a Internal Medicine healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659348027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Killingsworth, MD has received a total of $271.64 in payments from pharmaceutical and medical device companies, with $34.16 received in 2019. These payments were reported across 22 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($271.64).
As a Medicare-enrolled provider, Killingsworth has provided services to 8,257 Medicare beneficiaries, totaling 26,181 services with total Medicare billing of $764,299. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Manhattan, KS
- Active Since 03/03/2006
- Last Updated 07/24/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659348027
Products in Payments
- XARELTO (Drug) $47.48
- VESICARE (Drug) $38.59
- Ozempic (Drug) $22.72
- Myrbetriq (Drug) $22.01
- TROKENDI XR (Drug) $17.38
- JANUVIA (Drug) $14.77
- KEVEYIS (Drug) $13.24
- TRULICITY (Drug) $13.08
- JARDIANCE (Drug) $12.59
- CHANTIX (Drug) $12.41
- Victoza (Drug) $12.02
- MYRBETRIQ (Drug) $11.44
- SHINGRIX (Biological) $10.83
- PRALUENT (Drug) $10.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Manhattan
Travis Koeneke, Md, MD
Internal Medicine — Payments: $21,792
Internal Medicine $21,792
Preeti Singh, Md, MD
Internal Medicine — Payments: $1,367
Internal Medicine $1,367
Roger Peck, Md, MD
Internal Medicine — Payments: $969.45
Internal Medicine $969.45
Mrs. Segen Elizabeth Chase, M.d, M.D
Internal Medicine — Payments: $712.51
Internal Medicine $712.51
Matthew Floersch, M.d, M.D
Internal Medicine — Payments: $587.18
Internal Medicine $587.18
Kenna Fischman, Md, MD
Internal Medicine — Payments: $572.14
Internal Medicine $572.14